Warberg Asset Management LLC Has $140,000 Position in Catheter Precision, Inc. (NYSEAMERICAN:VTAK)

Warberg Asset Management LLC boosted its stake in shares of Catheter Precision, Inc. (NYSEAMERICAN:VTAKFree Report) by 362.9% during the fourth quarter, Holdings Channel.com reports. The fund owned 310,164 shares of the company’s stock after acquiring an additional 243,164 shares during the period. Warberg Asset Management LLC’s holdings in Catheter Precision were worth $140,000 at the end of the most recent reporting period.

Catheter Precision Stock Up 5.8 %

VTAK stock opened at $0.33 on Friday. The company’s 50-day moving average price is $0.36 and its two-hundred day moving average price is $0.61. The company has a debt-to-equity ratio of 0.12, a current ratio of 0.66 and a quick ratio of 0.65. Catheter Precision, Inc. has a 12 month low of $0.24 and a 12 month high of $8.40.

Catheter Precision Company Profile

(Free Report)

Catheter Precision, Inc designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company’s lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures.

See Also

Want to see what other hedge funds are holding VTAK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Catheter Precision, Inc. (NYSEAMERICAN:VTAKFree Report).

Receive News & Ratings for Catheter Precision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catheter Precision and related companies with MarketBeat.com's FREE daily email newsletter.